Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
School of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK.
Sci Adv. 2024 Jan 12;10(2):eadj2384. doi: 10.1126/sciadv.adj2384. Epub 2024 Jan 10.
Free fatty acid receptors 1 to 4 (FFA1 to FFA4) are class A G protein-coupled receptors (GPCRs). FFA1 to FFA3 share substantial sequence similarity, whereas FFA4 is unrelated. However, FFA1 and FFA4 are activated by long-chain fatty acids, while FFA2 and FFA3 respond to short-chain fatty acids generated by intestinal microbiota. FFA1, FFA2, and FFA4 are potential drug targets for metabolic and inflammatory conditions. Here, we determined the active structures of FFA1 and FFA4 bound to docosahexaenoic acid, FFA4 bound to the synthetic agonist TUG-891, and butyrate-bound FFA2, each complexed with an engineered heterotrimeric G protein (miniG), by cryo-electron microscopy. Together with computational simulations and mutagenesis studies, we elucidated the similarities and differences in the binding modes of fatty acid ligands to their respective GPCRs. Our findings unveiled distinct mechanisms of receptor activation and G protein coupling. We anticipate that these outcomes will facilitate structure-based drug development and underpin future research on this group of GPCRs.
游离脂肪酸受体 1 至 4(FFA1 至 FFA4)属于 A 类 G 蛋白偶联受体(GPCR)。FFA1 至 FFA3 具有显著的序列相似性,而 FFA4 则没有关联。然而,FFA1 和 FFA4 可被长链脂肪酸激活,而 FFA2 和 FFA3 则对肠道微生物群产生的短链脂肪酸作出响应。FFA1、FFA2 和 FFA4 是代谢和炎症疾病的潜在药物靶标。在这里,我们通过低温电子显微镜确定了与二十二碳六烯酸结合的 FFA1 和 FFA4、与合成激动剂 TUG-891 结合的 FFA4 以及与工程异源三聚体 G 蛋白(miniG)结合的丁酸盐结合的 FFA2 的活性结构。结合计算模拟和突变研究,我们阐明了脂肪酸配体与其各自 GPCR 结合模式的异同。我们的研究结果揭示了受体激活和 G 蛋白偶联的不同机制。我们预计这些结果将促进基于结构的药物开发,并为这组 GPCR 的未来研究提供支持。